Company expects to initiate Phase 1b study with CDI-988 in norovirus-infected healthy subjects later this year Lack of approved norovirus treatments or vaccines creates critical unmet medical need ...

Moderna, Inc.'s Q2 2025 earnings highlight a steep revenue decline post-pandemic, with just $0.1bn in revenue and a $(0.8bn) ...

Several studies have now demonstrated that trained immunity occurs in the airways to several pathogens and products, while its utility is yet to be determined.

In a memo, CEO Stéphane Bancel said the job cuts are needed to align the struggling vaccine maker’s cost structure with the ...

A deadly tick-borne illness, severe fever with thrombocytopenia syndrome (SFTS), continues to claim lives with no specific antiviral treatment.

Advanced light microscopy techniques have come into their own — and are giving scientists a new understanding of human biology and what goes wrong in disease ...

Bird flu fears have focused on the poultry and dairy industries and human health. But wild animals are threatened, too—at ...

This is the first time we’ve had access to an influenza genome from the 1918–1920 pandemic in Switzerland. It opens up new insights into the dynamics of how the virus adapt ...

But influenza viruses are slippery beasts ... “The whole reproduction system was damaged,” she says. “There was no social structure anymore.” Large animal die-offs could also throw whole ecosystems in ...

An announcement from Cocrystal Pharma ( ($COCP) ) is now available. Cocrystal Pharma announced on July 10, 2025, that its broad-spectrum protease ...

Influenza hemagglutinin subunit vaccines are more effective and offer better cross protection against various influenza virus challenges when combined with a mucosal adjuvant that enhances the ...